Assessment and treatment of the withdrawal syndrome in paediatric intensive care units
Open Access
- 1 January 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (5) , e18502
Abstract
Background: Sedoanalgesia secondary iatrogenic withdrawal syndrome (IWS) in paediatric intensive units is frequent and its assessment is complex. Therapies are heterogeneous, and there is currently no gold standard method for diagnosis. In addition, the assessment scales validated in children are scarce. This paper aims to identify and describe both the paediatric diagnostic and assessment tools for the IWS and the treatments for the IWS in critically ill paediatric patients. Methods: A systematic review was conducted according to the PRISMA guidelines. This review included descriptive and observational studies published since 2000 that analyzed paediatric scales for the evaluation of the iatrogenic withdrawal syndrome and its treatments. The eligibility criteria included neonates, newborns, infants, pre-schoolers, and adolescents, up to age 18, who were admitted to the paediatric intensive care units with continuous infusion of hypnotics and/or opioid analgesics, and who presented signs or symptoms of deprivation related to withdrawal and prolonged infusion of sedoanalgesia. Results: Three assessment scales were identified: Withdrawal Assessment Tool-1, Sophia Observation Withdrawal Symptoms, and Opioid and Benzodiazepine Withdrawal Score. Dexmedetomidine, methadone and clonidine were revealed as options for the treatment and prevention of the iatrogenic withdrawal syndrome. Finally, the use of phenobarbital suppressed symptoms of deprivation that are resistant to other drugs. Conclusions: The reviewed scales facilitate the assessment of the iatrogenic withdrawal syndrome and have a high diagnostic quality. However, its clinical use is very rare. The treatments identified in this review prevent and effectively treat this syndrome. The use of validated iatrogenic withdrawal syndrome assessment scales in paediatrics clinical practice facilitates assessment, have a high diagnostic quality, and should be encouraged, also ensuring nurses’ training in their usage.Keywords
This publication has 37 references indexed in Scilit:
- Defining sedation-related adverse events in the pediatric intensive care unitHeart & Lung, 2013
- Pentobarbital withdrawal and treatment in an infant in the pediatric cardiac intensive care unitJournal of Clinical Anesthesia, 2013
- Validity and generalizability of the Withdrawal Assessment Tool-1 (WAT-1) for monitoring iatrogenic withdrawal syndrome in pediatric patientsPain, 2012
- A trial of methadone tapering schedules in pediatric intensive care unit patients exposed to prolonged sedative infusions*Pediatric Critical Care Medicine, 2011
- Declaración PRISMA: una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisisMedicina Clinica, 2010
- Tolerance and Withdrawal From Prolonged Opioid Use in Critically Ill ChildrenPediatrics, 2010
- Sedation and analgesia in the pediatric intensive care unit following laryngotracheal reconstructionPediatric Anesthesia, 2009
- The Withdrawal Assessment Tool–1 (WAT–1): An assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients*Pediatric Critical Care Medicine, 2008
- Withdrawal symptoms in critically ill children after long-term administration of sedatives and/or analgesics: A first evaluation*Critical Care Medicine, 2008
- Minimizing Tolerance and Withdrawal to Prolonged Pediatric Sedation: Case Report and Review of the LiteratureJournal of Intensive Care Medicine, 2007